Case Study

OCT Clinical For Futura Medical: Completing Recruitment In 4 Countries In A Study Of A Topical Gel For Male Erectile Dysfunction

Source: OCT Clinical
GettyImages-1169924346 patient data collection

In their meaningful collaboration, OCT Clinical, a leading CRO from Eastern Europe, teamed up with UK-based Futura Medical to conduct the FM71 study. This study evaluated the innovative MED3000 topical gel for the treatment of erectile dysfunction (ED).

The confirmatory trial successfully enrolled 100 male participants with diverse demographics across four countries – Poland, Georgia, the USA, and Bulgaria. Efficiently completed and ahead of schedule, the study marks a significant advancement in ED treatment options. It showcases how a CRO’s expertise in managing complex, multi-national clinical trials can contribute to the success of a study. Download the full text to learn more about the outcomes of this study.

Download the full text to learn more about this study’s outcomes.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader